These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 16332703)

  • 21. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations.
    Rumpsfeld M; McDonald SP; Johnson DW
    J Am Soc Nephrol; 2006 Jan; 17(1):271-8. PubMed ID: 16306167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients.
    Aguilera A; Bajo MA; Rebollo F; Díez JJ; Díaz C; Paiva A; Codoceo R; Selgas R
    Adv Perit Dial; 2002; 18():212-7. PubMed ID: 12402621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal small solute transport rate is related to the malnutrition inflammation score in peritoneal dialysis patients.
    Sezer S; Elsurer R; Afsar B; Arat Z; Ozdemir NF; Haberal M
    Nephron Clin Pract; 2007; 107(4):c156-62. PubMed ID: 17957127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is malnutrition an independent predictor of mortality in peritoneal dialysis patients?
    Chung SH; Lindholm B; Lee HB
    Nephrol Dial Transplant; 2003 Oct; 18(10):2134-40. PubMed ID: 13679492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
    Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
    Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between baseline peritoneal membrane status and pre-dialytic characteristics.
    Balafa O; Vlahu C; Sampimon D; Coester AM; Struijk DG; Krediet RT
    Adv Perit Dial; 2010; 26():16-20. PubMed ID: 21348373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients.
    Heaf JG; Sarac S; Afzal S
    Nephrol Dial Transplant; 2005 Oct; 20(10):2194-201. PubMed ID: 16030031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis.
    Lam MF; Leung JC; Lo WK; Tam S; Chong MC; Lui SL; Tse KC; Chan TM; Lai KN
    Nephrol Dial Transplant; 2007 May; 22(5):1445-50. PubMed ID: 17277343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis.
    Malik AR; Little MA; Henriksson M; Tam FW; Brown EA
    J Nephrol; 2007; 20(3):340-9. PubMed ID: 17557268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.
    Wiggins KJ; McDonald SP; Brown FG; Rosman JB; Johnson DW
    Nephrol Dial Transplant; 2007 Oct; 22(10):3005-12. PubMed ID: 17545674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cystatin C: a surrogate marker for the characteristics of peritoneal membrane in dialysis patients.
    Al-Wakeel JS; Hammad D; Memon NA; Tarif N; Shah I; Chaudhary A
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):227-31. PubMed ID: 19237809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.
    Enia G; Panuccio V; Cutrupi S; Pizzini P; Tripepi G; Mallamaci F; Zoccali C
    Nephrol Dial Transplant; 2007 Feb; 22(2):538-44. PubMed ID: 17082213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
    Cooper S; Iliescu EA; Morton AR
    Adv Perit Dial; 2001; 17():244-7. PubMed ID: 11510285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.